Global Orphan Drugs Market Poised to Grow at Double-Digit CAGR to Surpass US$ 300 Bn by 2025-End
The global orphan drugs market is likely to grow at double-digit CAGR to surpass US$ 300 Bn in revenues by the end of 2025. High return on investment on Phase III orphan drugs is likely to provide an impetus to the demand for orphan drugs. These insights are according to a new research report added to the repository of Market Research Reports Search Engine (MRRSE). The report titled "Orphan Drugs Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and...
View full press release